Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Shore

Showing results (31-40 of 191) with videos related to

Pageof 20
Sort By:
Pharmacoeconomics - Open|October 24, 2019
A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource UseSreevalsa Appukkuttan, Krishna Tangirala, Svetlana Babajanyan, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in womenJean L Fourcroy, Bret Berner, Yu-Kun Chiang, et al.
Cancer Treatment Reviews|March 27, 2019
Emerging therapeutic targets for patients with advanced prostate cancerFred Saad, Neal Shore, Tian Zhang, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2024
Impact of a rash management guide in patients receiving apalutamide for high-risk localized prostate cancer in the Apa-RP studyNeal Shore, Jason Hafron, Daniel Saltzstein, et al.
Current Urology Reports|August 16, 2012
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of careDavid R Staskin, Kenneth M Peters, Scott MacDiarmid, et al.
European Urology|May 20, 2019
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal CystoscopyBadrinath Konety, Neal Shore, Andrew Karim Kader, et al.
Future Oncology (London, England)|February 16, 2023
Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancerNeal Shore, Viviana Garcia-Horton, Emi Terasawa, et al.
Prostate Cancer and Prostatic Diseases|October 17, 2024
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journeyHannah D McManus, Tanya Dorff, Alicia K Morgans, et al.
Journal of Cancer|February 27, 2016
Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring SystemMaher Albitar, Wanlong Ma, Lars Lund, et al.
European Urology|December 4, 2014
Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trialRoger L Sur, Neal Shore, James L'Esperance, et al.
Pageof 20

Showing results (31-40 of 191) with videos related to

Sort By:
Pageof 20
Pharmacoeconomics - Open|October 24, 2019
A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource UseSreevalsa Appukkuttan, Krishna Tangirala, Svetlana Babajanyan, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in womenJean L Fourcroy, Bret Berner, Yu-Kun Chiang, et al.
Cancer Treatment Reviews|March 27, 2019
Emerging therapeutic targets for patients with advanced prostate cancerFred Saad, Neal Shore, Tian Zhang, et al.
Prostate Cancer and Prostatic Diseases|July 5, 2024
Impact of a rash management guide in patients receiving apalutamide for high-risk localized prostate cancer in the Apa-RP studyNeal Shore, Jason Hafron, Daniel Saltzstein, et al.
Current Urology Reports|August 16, 2012
Percutaneous tibial nerve stimulation: a clinically and cost effective addition to the overactive bladder algorithm of careDavid R Staskin, Kenneth M Peters, Scott MacDiarmid, et al.
European Urology|May 20, 2019
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal CystoscopyBadrinath Konety, Neal Shore, Andrew Karim Kader, et al.
Future Oncology (London, England)|February 16, 2023
Safety differences across androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancerNeal Shore, Viviana Garcia-Horton, Emi Terasawa, et al.
Prostate Cancer and Prostatic Diseases|October 17, 2024
Navigating therapeutic sequencing in the metastatic castration-resistant prostate cancer patient journeyHannah D McManus, Tanya Dorff, Alicia K Morgans, et al.
Journal of Cancer|February 27, 2016
Predicting Prostate Biopsy Results Using a Panel of Plasma and Urine Biomarkers Combined in a Scoring SystemMaher Albitar, Wanlong Ma, Lars Lund, et al.
European Urology|December 4, 2014
Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trialRoger L Sur, Neal Shore, James L'Esperance, et al.
Pageof 20